Skip to main content

Table 2 Odds of testing positive for P. falciparum infection during the follow-up survey: results from three geospatial models defined by baseline infection, anti-AMA-1 antibody prevalence, and anti MSP-1 19 antibody prevalence adjusted for age

From: Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections

Risk factor

Number tested

Malaria in second year n. %

OR 95% CI

Wald test P-value

Area under the ROC curve

PCR individual infection in baseline survey*

     

Neg

1,763

827 [46.9]

1

<0.001

0.560

Pos

905

521 [57.6]

1.58 [1.31-1.83]

  

PCR prevalence

     

Satscan exposure category

792

319 [40.3]

1

0.181

0.620

coldspot

1,728

864 [50.0]

1.35 [0.87-2.09]

<0.001

0.628

neither

726

500 [68.9]

4.54 [2.68-7.72]

0.966

0.597

hotspot

804

390 [48.5]

1

0.013

 

Kernel exposure quartiles

819

387 [47.2]

0.99 [0.60-1.64]

<0.001

 

<14.9

818

331 [40.5]

0.53 [0.32-0.88]

0.165

 

15-21.3

805

575 [71.4]

3.45 [2.06-5.75]

0.042

 

21.4-27.1

816

420 [51.5]

1

0.003

 

>27.1

794

344 [43.3]

0.69 [0.41-1.16]

  

Weighted exposure quartiles

807

372 [46.1]

0.58 [0.35-0.98]

  

<18.9

799

520 [65.1]

2.21 [1.31-3.73]

  

19-23.2

     

23.3-26.5

     

>26.5

     

AMA-1 individual prevalence

     

No

1,262

594 [47.1]

1

<0.001

0.554

Yes

1,071

593 [55.4]

1.45 [1.21-1.72]

  

AMA-1 prevalence

     

Satscan exposure category

904

310 [34.3]

1

<0.001

0.647

coldspot

1,092

554 [50.7]

2.65 [1.69-4.15]

<0.001

0.618

neither

1,250

819 [65.5]

5.84 [3.75-9.10]

0.002

0.609

hotspot

814

308 [37.8]

1

<0.001

 

Kernel exposure quartiles

813

414 [50.9]

2.26 [1.35-3.79]

<0.001

 

<27.9

812

425 [52.3]

2.62 [1.57-4.39]

0.154

 

28-38.9

807

536 [66.4]

5.16 [3.06-8.69]

<0.001

 

39-53.0

804

325 [40.4]

1

<0.001

 

>53.0

809

357 [44.1]

1.45 [0.86-2.44]

  

Weighted exposure quartiles

800

476 [59.5]

3.50 [2.07-5.91]

  

<18.9

803

498 [62.0]

3.33 [1.97-5.62]

  

19-23.9

     

24 -26.9

     

>26.9

     

MSP-1 19 individual prevalence

     

No

1,730

924 [53.4]

1

0.196

0.541

Yes

681

341 [50.1]

0.88 [0.73-1.06]

  

MSP prevalence

     

Satscan exposure category

1,703

992 [58.2]

1

0.040

0.591

coldspot

967

493 [51.0]

0.64 [0.41-0.98]

<0.001

0.622

neither

576

198 [34.0]

0.21 [0.13-0.34]

0.773

0.625

hotspot

806

418 [51.9]

1

0.008

0.631

Kernel exposure quartiles

835

440 [52.7]

1.08 [0.65-1.78]

<0.001

 

<12.9

808

538 [66.6]

2.02 [1.21-3.38]

0.715

 

13-17.3

797

287 [36.0]

0.34 [0.20-0.55]

0.006

 

17.4-25.4

805

415 [51.6]

1

<0.001

 

>25.4

813

430 [52.9]

1.10 [0.66-1.81]

  

Weighted exposure quartiles

802

533 [66.5]

2.08 [1.23-3.51]

  

<16.5

796

278 [34.9]

0.35 [0.21-0.57]

  

16.6-18.3

     

18.4-22.7

     

>22.7

     

MSP-1 19 &/ or AMA - 1 individual prevalence

     

No

986

253 [25.6]

1

0.986

0.530

Yes

1,237

466 [37.7]

1.00 [0.78-1.29]

  

MSP-1 19 &/or AMA-1 prevalence

     

Satscan exposure category

-

400 [48.4]

-

-

-

coldspot

-

357 [44.6]

-

-

0.604

neither

-

386 [47.0]

-

-

0.530

hotspot

827

540 [67.8]

1

0.082

 

Kernel exposure quartiles

800

402 [49.3]

0.63 [0.37 - 1.07]

0.310

 

<44.5

822

380 [47.4]

0.77 [0.46-1.28]

0.001

 

44.6-51.4

797

372 [45.6]

2.44 [1.44-4.14]

0.507

 

51.5-59.3

816

502 [64.0]

1

0.063

 

>59.4

801

 

0.84 [0.49-1.42]

0.023

 

Weighted exposure quartiles

815

 

0.60 [0.36-1.03]

  

<16.5

784

 

1.86 [1.09-3.18]

  

16.6-18.3

     

18.4-22.7

     

>22.7

     
  1. *Only individuals who were tested at both baseline and year 1.